Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Anniversary
Archive
Authors
Blog
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Anniversary
Archive
Authors
Blog
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 33, Issue e1
Analysis of FDA’s Vuse market authorisation: limitations and opportunities
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Special communication
Analysis of FDA’s Vuse market authorisation: limitations and opportunities
Online download statistics by month:
Online download statistics by month: February 2023 to September 2024
Abstract
Full
Pdf
Feb 2023
1479
91
44
Mar 2023
813
37
14
Apr 2023
383
16
5
May 2023
293
6
4
Jun 2023
254
13
4
Jul 2023
269
3
3
Aug 2023
268
13
2
Sep 2023
254
1
6
Oct 2023
347
5
4
Nov 2023
259
3
1
Dec 2023
285
4
4
Jan 2024
268
8
2
Feb 2024
277
2
1
Mar 2024
702
26
19
Apr 2024
578
19
14
May 2024
482
10
6
Jun 2024
79
3
2
Jul 2024
150
10
6
Aug 2024
94
2
3
Sep 2024
64
5
6
Total
7598
277
150
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF